Die Differentialdiagnose der Gerinnungsstörungen

  • Pietro de Nicola
Conference paper
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 6)

Zusammenfassung

Die Einteilung der Gerinnungsstörungen nach physiopathologischen Gesichtspunkten bildet einen Leitfaden für die Differentialdiagnose der einzelnen Gerinnungsstörungen nach einem rationellen Schema. Für mehrere Störungen erhielt man eine Anordnung, die den modernen Gerinnungsschemata nahekommt. Andere hingegen ließen sich nur provisorisch einordnen, was die noch in einigen Phasen der Blutgerinnung herrschenden Unsicherheiten widerspiegelt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ackroyd, J. P.: The cause of thrombocytopenia in sedormid purpura. Clin. Sci. 8, 269 (1949); Sedormid purpura: an immunologic study of a form of drug hypersensitivity. Progr. in Allergy 3, 531 (1952).Google Scholar
  2. Aggeler, P. M.: Blood platelets. In E. V. Cowdry: Laboratory technique in biology and medicine. Baltimore: Williams and Wilkins Co. 1952.Google Scholar
  3. Aggeler, P. M. and S. P. Lucia: Hemorrhagic disorders. Chicago: Univ. of Chicago Press 1949.Google Scholar
  4. Aggeler, P. M., S. G. White, M. B. Glendening, E. W. Page, T. B. Leake and G. Bates: Plasma thromboplastin component (PTC deficiency: a new disease resembling hemophilia). Proc. Soc. Exper. Biol. a. Med. 79, 692 (1952).Google Scholar
  5. Alexander, B.: Ac-globuline et SPCA: deux facteurs plasmatiques de la conversion de la prothrombine. Étude et revue cliniques et biologiques. Rev. d’Hématol. 7, 168 (1952).Google Scholar
  6. Alexander, B., A. De Vries, R. Goldstein and G. Landwehr: A prothrombin conversion accelerator in serum. Science (Lancaster, Pa.) 109, 545 (1949).Google Scholar
  7. Alexander, B., and R. Goldstein: Coagulation defect in hepatic disorders. Deficiency of prothrombin — conversion accessory substances. J. Clin. Invest. 29, 795 (1950).PubMedCrossRefGoogle Scholar
  8. Alexander, B. and G. Landwehr: Labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation. J. Clin. Invest. 30, 252 (1951).PubMedCrossRefGoogle Scholar
  9. Alexander, B. and G. Landwehr: Studies of hemophilia. 1. The control of hemophilia by repeated infusions of normal human plasma. J. Amer. Med. Assoc. 138, 174 (1948); Studies of hemophilia. II. The assay of the antihemophilic clot-promoting principle in normal human plasma with some observations on the relative potency of certain plasma fractions. J.Clin. Invest. 27, 98 (1948).Google Scholar
  10. Allen, J. G., P. J. Moulder, R. M. Elghammer, B. J. Grossman, C. L. Mckren, M. Sanderson, W. Egner and J. J. Crosbie: A protamine titration as an indicator of a clotting defect in certain hemorrhagic states. J. Labor, a. Clin. Med. 34, 743 (1949).Google Scholar
  11. Amato, M., E A. Camera: Contributo alla conoscenza di una nuova malattia emorragica analoga alla emofilia (Deficienza di fattore P. T. C.). Pediatria 61, 336 (1953).PubMedGoogle Scholar
  12. André, J., B. Dreyfus, S. Jacob et G. Ley: Sur les formes hémorrhagiques des myélomes. Rev. d’Hématol. 7, 296 (1952).Google Scholar
  13. Astrup, T.: Biochemistry of blood coagulation. Acta physiol. scand. (Stockh.) 7, suppl. 24 (1944).Google Scholar
  14. Astrup, T., Fibrinolysis. Acta haematol. (Basel) 7, 271 (1952).Google Scholar
  15. Baffi, V., E A. Camera: Contributo allo studio della Malattia emorragica da deficit di PTC. Pediatria 61, 889 (1953).PubMedGoogle Scholar
  16. Baserga, A., U. P. De Nicola: Über den Verwertungsgrad des Prothrombins bei hämorrhagischen Diathesen. Schweiz, med. Wschr. 1949, 801.Google Scholar
  17. Baserga, A., Le Malattie Emorragiche. Milano: Soc. Ed. Libr. 1950; Enfermedades hemorragicas. Buenos Aires: Vallardi 1952.Google Scholar
  18. Baserga, A., Normal clotting time after transfusion in hemophilia. Lancet 1951, 1039.Google Scholar
  19. Baserga, A. and R. Vahi: Hyaluronidase and prothrombin consumption test. Experientia (Basel) 6, 471 (1950).CrossRefGoogle Scholar
  20. Baserga, A., Y G. Meyer: EL test de actividad del tromboplastinogeno. Prensa med. argent. 40, 1333 (1954).Google Scholar
  21. Baserga, A., E P. Rosti: Sull’ipoprotrombinemia da estere etilico dell’acido 4-4’-diossidicumarinil-acetico negli epatopazienti. Rass. giuliana di med. 7, 27 (1951).Google Scholar
  22. Baserga, A. and R. Furian: Prothrombin consumption during menses. Lancet 1950, 460.Google Scholar
  23. Bayerle, H., U. R. Marx: Über ein Zweistufenverfahren zur Bestimmung von Prothrombin in Blut und Plasma. Hoppe-Seylers Z. 283, 248 (1949).CrossRefGoogle Scholar
  24. Beaumont, J. L., et J. Bernard: Hypoconvertinémie congénitale hemorrhagipare. Presse méd. 60, 1469 (1952); Syndrome hémorrhagique congénital du au défaut du facteur de coagulation récemment isolé sous le nom de facteur VII, convertine, S. P. C. A. Acta med. scand. (Stockh.) 145, 200 (1953).Google Scholar
  25. Beaumont, J. L., A. Cayla, H. Dupin et J. Bernard: Syndrome hémorrhagique congénital du au défaut d’ un facteur plasmatique prothromboplastique different du facteur antihémophilique (Hämophilie B). Sang 24, 488 (1953).PubMedGoogle Scholar
  26. Bernard, J., S. Inceman, M. Zara et D. Christol: La dysglobulinemie maligne hémorrhagipare. Rev. d’Hématol. 7, 264 (1952).Google Scholar
  27. Bernard, J., et J. P. Soulier: Sur une nouvelle varieté de dystrophie thrombocytaire hémorrhagipare congénitale. Semaine Hóp. 24, 3217 (1948).Google Scholar
  28. Bernfeld, P., and M. Stefanini: Characteristic electrophoretic patterns in hemophilia and idiopathic thrombocytopenia. Proc. Soc. Exper. Biol. a. Med. 77, 582 (1951).Google Scholar
  29. Bernfeld, P., M. Stefanini, E. D. Berkowitz and F. B. Hennessey: Electrophoretic plasma protein patterns in families with hemophilia. Proc. Soc. Exper. Biol. a. Med. 83, 311 (1953).Google Scholar
  30. Biggs, R., A. S. Douglas and R. G. Macfarlane: The formation of thromboplastin in human blood. J. of Physiol. 119, 89 (1953).Google Scholar
  31. Biggs, R., A. S. Douglas and R. G. Macfarlane, J. V. Dacie, W. R. Pitney, C. Merskey and J. R. O’Brien: Christmas disease: a condition previously mistaken for hemophilia. Brit. Med. J. 2, 1378 (1952).Google Scholar
  32. Biggs, R., and R. G. Macfarlane: The formation of thromboplastin in human blood. J. of Physiol. 119, 89 (1953).Google Scholar
  33. Braunsteiner, H.: Weitere Untersuchungen von Thrombocyten im Elektronenmikroskop. Acta haematol. (Basel) 8, 170 (1950).Google Scholar
  34. Braunsteiner, H., U. F. Pakesch: Elektronenmikroskopische Untersuchung der Wirkung eines starken Plättchenagglutinins bei essentieller Thrombopenie auf normale Plättchen. Klin. Wschr. 1954, 79.Google Scholar
  35. Brecher, G., M. Schneiderman and E. Cronkite: The reproducibility and constancy of the platelet count. Amer. J. Clin. Path. 23, 15 (1953).Google Scholar
  36. Breda, R., E R. Bernardi: L’influenza del calcio nella reazione trombina-fibrinogeno. Rass. Fisiopat. 22, 379 (1950).PubMedGoogle Scholar
  37. Brinkhous, K. M.: Clotting defect in hemophilia; deficiency in a plasma factor required for platelet utilization. Proc. Soc. Exper. Biol. a. Med. 66, 117 (1947).Google Scholar
  38. Brinkhous, K. M., R. D. Langdell, G. D. Penick, J. B. Graham and R. H. Wagner: Newer approaches to the study of hemophilia and hemophilioid state. J. Amer. Med. Assoc. 154, 481 (1954).CrossRefGoogle Scholar
  39. Brönniman, R.: Kongenitale Afibrinogenämie. Mitteilung eines Falles mit multiplen Knochen- cysten und Bildung eines spezifischen Antikörpers (Antifibrinogen) nach Bluttransfusionen. Acta haematol. (Basel) 11, 40 (1954).Google Scholar
  40. Cervini, C., E G. Ficola: La fibrinolisi ematica. Clinica nuova 11, 399 (1950); Fibrinolisi ematica ed elettroshock. Boll. Soc. ital. Biol. sper. 27, 1534 (1951).PubMedGoogle Scholar
  41. Ciulla, U., E G. Santoni: Il fattore VII della coagulazione nella gravidanza e nel puerperio patologico. Ann. Ostetr. 76, 164 (1954).Google Scholar
  42. Colli, A., E P. Rosti: La prova del tromboplastinogeno per la diagnosi delle sindromi emofiliache. Haematologica (Pavia) 38, 513 (1954).Google Scholar
  43. Colli, A., E P. Rosti: La valutazione degli stati di ipoe di ipercoagulabilità attra verso Jo studio dei fenomeni di superficie. Boll. Soc. med.-chir. Pavia 67, 1365 (1953).Google Scholar
  44. Collins, J. S., and D. G. Ferriman: Hemophilia-like syndrome from anticoagulants affecting the production of thromboplastin. Lancet 1952, 712.Google Scholar
  45. Cramer, R., P. Flückiger, C. Gasser, F. Koller, A. Loeliger and M. Matter: Hemophilia B. Two cases of hereditary hemophilia due to a deficiency of a new clotting factor (Christmas factor). Acta haematol. (Basel) 10, 65 (1953).Google Scholar
  46. Cronkite, E. P., and G. Brecher: Defects in hemostasis produced by whole body irradiation. Trans. Fifth Macy Conference on Blood Clotting and Allied Problems. New York: Josiah Macy, Jr. Foundation 1952.Google Scholar
  47. Cutbush, M., P. L. Mollison and D. M. Parkin: A new human blood group. Nature (London) 165, 188 (1950).CrossRefGoogle Scholar
  48. Dameshek, W.: Method for simultaneous enumeration of blood platelets and reticulocytes with consideration of normal platelet count in men and woman. Arch. Int. Med. 50, 579 (1932).CrossRefGoogle Scholar
  49. Dameshek, W. and E. B. Miller: The megacaryocvtes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood 1, 27 (1946).PubMedGoogle Scholar
  50. Dameshek, W. and M. Stefanini: Idiopathic thrombocytopenic purpura. Med. Clin. X. Amer. 1953, 1395.Google Scholar
  51. Dausset, J., P. Delafontaine et Y. Fleuriot: Agglutination et destruction in vitro des plaquettes normales par le sérum d’une malade atteinte de purpura thrombopénique aigu. Inhibition par ce sérum de la rétraction du caillot normal. Sang 23, 373 (1952).PubMedGoogle Scholar
  52. Deutsch, E.: Die Hemmkörperhämophilie. Wien: Springer 1950.Google Scholar
  53. Deutsch, E., H. Frischauf, U. E. Keibl: Hemmkörperhämophilie als eine Komplikation bei essentieller Thrombopenie. Acta haematol. (Basel) 6, 156 (1951).Google Scholar
  54. Donhoffer, S., H. Greiner, U. K. Mesko: Über die Gerinnungsstörung im Ikterus. Z. exper. Med. 110, 315 (1942).Google Scholar
  55. Duckert, F., F. Koller and M. Matter: Purification and physiological properties of factor VII from plasma and serum. Separation from prothrombin. Proc. Soc. Exper. Biol. a. Med. 82, 259 (1953).Google Scholar
  56. Duckert, F., A. Loeliger et F. Koller: Sur un nouveau facteur de la coagulation du sang. Helvet. chim. Acta 34, 2431 (1951).Google Scholar
  57. Esser, H., U. R. Steinhausen: Über ein thrombopathisches Blutungsübel als vermutliche Vorstufe der essentiellen Thrombopenie. Dtsch. Arch. klin. Med. 196, 364 (1949).Google Scholar
  58. Fanconi, G.: Über Störungen des Wasser-, Kochsalz-und Plasmaeiweißhaushaltes. Schweiz, med. Wschr. 1946, 791.Google Scholar
  59. Fantl, P., and M. Nance: Acceleration of thrombin formation by plasma component. Nature (London) 158, 708 (1946).CrossRefGoogle Scholar
  60. Favre-Gilly, J.: Les états hémorragiques et la notion de fibrinopénie. Paris: Vigot 1947.Google Scholar
  61. Favre-Gilly, J., Fibrinolyse et grossesses interrompues par sensibilisation au facteur FF. Rev. d’Hématol. 7, 60 (1952).Google Scholar
  62. Feissly, R., et H. Lüdin: Microscopie par contraste de phases. Rev. d’Hématol. 4, 481 (1949).Google Scholar
  63. Fell, C., N. Ivanovic, S. A. Johnson and W. H. Seegers: Differentiation of plasma anti-thrombin activities. Proc. Soc. Exper. Biol. a. Med. 85, 199 (1954).Google Scholar
  64. Fiala, S.: A thermolabile inhibitor of plasma coagulation. Nature (London) 167, 279 (1951); On the role of a protein inhibitor in the first stage of blood coagulation. Arch, internat. Physiol. 58, 386 (1951).Google Scholar
  65. Fiala, S. and K. Roth: Interaction of hyaluronidase writh thromboplastic components of blood coagulation. Federat. Proc. 11, 344 (1952).Google Scholar
  66. Fieschi, A.: Morphologie pathologique des thrombocytes. IV. Internat. Congr. Hematol., Amsterdam, 1953; Morfologia e istochimica patologica delle piastrine. Quaderni della coagul. 2, 19 (1954).Google Scholar
  67. Flückiger, P., A. Hässig U. F. Koller: Über den Thrombocvten-Coombs-Test. Schweiz, med. Wschr. 1953, 1035.Google Scholar
  68. Folin, O., and V. Ciocalteu: On tvrosine and tryptophane determinations in proteins. J. of Biol. Chem. 78, 627 (1922).Google Scholar
  69. Fonio, A.: Über das funktionelle Verhalten der isolierten Strukturelemente der Thrombocyten, des Hyalomers und des Granulomers. Acta haematol. (Basel) 6, 207 (1951).Google Scholar
  70. Fonio, A., Über die Wirkung des Hvalomers der Thrombocyten auf den Retraktionsvorgang. Acta haematol. (Basel) 8, 363 (1952).Google Scholar
  71. Fonio, A., Über die dritte Phase der Blutgerinnung und über die Funktion der Strukturelemente der Thrombocyten. Erg. inn. Med. N. F. 4, 1 (1953).Google Scholar
  72. Forell, M. M., U. F. Koller: Beurteilung der Leberfunktion durch die Bestimmung von Faktor V, Faktor VII und Prothrombin. Wirkung von Synkavit und Vitamin K2. Münch, med. Wschr. 1953, 433.Google Scholar
  73. Frick, P. G.: Hemophilia-like disease following pregnancy. With transplacental transfer of an aquired circulating anticoagulant. Blood 8, 598 (1953).PubMedGoogle Scholar
  74. Frick, P. G. and P. S. Hägen: Congenital familial deficiency of the stable prothrombin conversion factor: restudy of case originally reported as “idiopathic hypoprothrombinemia”. J. Labor, a. Clin. Med. 42, 212 (1953).Google Scholar
  75. Gagliardi, L.: Studio clinico dell’anticoagulante 3-(l-fenil-propil)-4-idrossicumarina (Marcumar) e del suo antidoto (vitamin Kx). Minerva ginecol. 5, 456 (1953).Google Scholar
  76. Gitlin, D., and W. H. Borgen: Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. Blood 8, 679 (1953).PubMedGoogle Scholar
  77. Gottlebe, P.: Die Prothrombinbestimmung als Leberfunktionprüfung. Dtsch. Arch. klin. Med. 197, 397 (1950).PubMedGoogle Scholar
  78. Graham, J. B., and K. M. Brinkhous: Christmas disease. Brit. Med. J. 2, 97 (1953).PubMedCrossRefGoogle Scholar
  79. Graham, T. B., W. Mclendon and K. M. Brinkhous: Mild hemophilia: an allelic form of the disease. Amer. J. Med. Sci. 225, 46 (1953).PubMedGoogle Scholar
  80. Guest, M. M., B. M. Daly, A. G. Ware and W. H. Seegers: A study of antifibrinolytic activity in the plasmas of various animal species. J. Clin. Invest. 27, 785 (1948).CrossRefGoogle Scholar
  81. Halse, T.: Heparin, Heparinoide, Dicumarol. Stuttgart: Hirzel 1950.Google Scholar
  82. Harrington, W. J., J. F. Desforges, F. Stohlman, C. B. Crow and W. C. Moloney: Studies on a case of actue antithromboplastinemia. J. Labor, a. Clin. Med. 36, 84 (1951).Google Scholar
  83. Harrington, W. J., V. Minnich, J. W. Hollingsworth and C. V. Moore: Demonstration of a thrombocytopenic factor in the blood of patients with idiopathic thrombocytopenic purpura. J. Labor, a. Clin. Med. 86, 1 (1951).Google Scholar
  84. Harrington, W. J., C. C. Sprague, V. Minnich, C. V. Moore, R. C. Aulvin and R. Dubach: Immunologic mechanism in idiopathic thrombocytopenic purpura. Ann. Int. Med. 38, 433 (1953).PubMedGoogle Scholar
  85. Hartert, H.: Die Thrombelastographie. Eine Methode zur physikalischen Analyse des Blut- gerinnungsvorganges. Z. exper. Med. 117, 189 (1951).Google Scholar
  86. Hartert, H., Klinische Blutgerinnungsstudien mit der Thrombelastographie. Dtsch. Arch. klin. Med. 199, 284, 293, 402, 414 (1952).Google Scholar
  87. Hartert, H., U. I. Hartert: Klinische Erfahrungen mit einem neuen hochwirksamen Dicumarolderivat. Klin. Wschr. 1953, 852.Google Scholar
  88. Hartmann, F., U. H. Lange: Untersuchungen über den Prothrombin- und Ac-Globulin-Gehalt des Blutes bei Leberschäden. Dtsch. Arch. klin. Med. 197, 438 (1950).PubMedGoogle Scholar
  89. Heilmeyer, L., U. H. Begemann: Blutkrankheiten. Berlin-Göttingen-Heidelberg: Springer-Verlag 1951.Google Scholar
  90. Hirschboeck, J. S.: The effect of operation and illness on clot retraction. Description of a new method. J. Labor, a. Clin. Med. 33, 347 (1948).Google Scholar
  91. Hoigne, R., U. H. Storck: Über die Bedeutung der Thrombocyten bei allergischen Vorgängen. II. Mitteilung: Thrombocytenagglutination in Patientenblut nach Zugabe von Allergenen. Schweiz, med. Wschr. 1953, 718.Google Scholar
  92. Honorato, C. R.: Plasmatic co-factor of thromboplastin: its adsorption with prothrombin and fibrinogen, by alumina and tricalcium phosphate gels. Amer. J. Physiol. 150, 381 (1947).PubMedGoogle Scholar
  93. Innerfield, L., A. Angrist and J. W. Benjamin: The antithrombin titer in actue pancreatitis. Amer. J. Med. 12, 24 (1952).CrossRefGoogle Scholar
  94. Jacox, R. F.: Studies on the activation of a serum “prothrombin-conversion factor”. J. Clin. Invest. 28, 492 (1949).CrossRefGoogle Scholar
  95. Johnson, S. A.: Activation of purified prothrombin with hemophilic plasma. Amer. J. Clin. Path. 23, 875 (1953).Google Scholar
  96. Johnson, S. A., J. Rutzky, C. L. Schneider and W. H. Seegers: Activation of purified prothrombin with hemophilic plasma. Proc. 4th Internat. Congr. Hemat. 1952.Google Scholar
  97. Jorpes, E.: Recent trends in anticoagulant therapy of thrombosis. Acta haematol. (Basel) 7, 257 (1952).Google Scholar
  98. Jürgens, J.: Déficience congénitale du facteur VII. IV. Internat. Congr. Hematol., Amsterdam 1953.Google Scholar
  99. Jürgens, J., Der Exponentiator, ein Tomogramm zur einheitlichen prozentualen Schnellberechnung von Blutgerinnungsfaktoren. Ärztl. Wschr. 1954, 420.Google Scholar
  100. Jürgens, R.: Die erblichen Thrombopathien. Erg. inn. Med. 53, 795 (1937).Google Scholar
  101. Jürgens, R., Wirkung von Vitamin KL auf die Dicumarol-Hypoprothrombinämie und die Accelerator-faktoren am lebergeschädigten Kaninchen und nach Leberexstirpation der Katze. Acta haematol. (Basel) 7, 143 (1952).CrossRefGoogle Scholar
  102. Jürgens, R., U. A. Ferlin: Über den sog. Prothrombinkonsumptionstest bei Hämophilie (Hämophilie, Konduktorinnen) und bei konstitutioneller Thrombopathie (V. Willebr and-Jürgens). Schweiz, med. Wschr. 1950, 1098.Google Scholar
  103. Jürgens, R., U. A. Studer: Zur Wirkung des Thrombins. Helvet. physiol. Acta 6, 130 (1948).Google Scholar
  104. Koller, F.: Das Vitamin K. Leipzig: Georg Thieme 1941.Google Scholar
  105. Koller, F., C. Gasser, G. Krüsi U. G. De Muralt: Purpura fulminans nach Scharlach mit Faktor V-Mangel und Antithrombinüberschuß. Acta haematol. (Basel) 4, 33 (1950).Google Scholar
  106. Koller, F., U. H. Jacob: Über ein neues hochaktives Antikoagulants mit protrahierter Wirkung (Marcoumar). Schweiz, med. Wschr. 1953, 476.Google Scholar
  107. Koller, F., A. Loeliger and F. Duckert: Experiments on a new clotting factor (factor VII). Acta haematol. (Basel) 6, 1 (1951).Google Scholar
  108. Koller, F., A. Loeliger and F. Duckert, U. H. Hit-Wang: Uber einen neuen Gerinnungsfaktor (Faktor VII) und Scine klinische Bedeutung. Dtsch. Med. Wtschr. 1952, 528.Google Scholar
  109. Koller, F., U. P. Fluckiger: Fortschritte in der Handhabung der Dicumaroltherapie. Vereinfachung der Kontrolle. Vitamin Kx als Antidot. Helvet. med. Acta 19, 411 (1952).Google Scholar
  110. Langdell, R. D., J. B. Graham and K. M. Brinkhous: Prothrombin utilization during clotting. Comparison of results with 2-stage and 1-stage methods. Proc. Soc. Exper. Biol. a. Med. 74, 424 (1950).Google Scholar
  111. Langdell, R. D., R. D. Wagner and K. M. Brinkhous: Effect of antihemophilic factor on one-stage clotting tests. J. Labor, a. Clin. Med. 41, 637 (1953).Google Scholar
  112. Lasch, H. G., U. A. Linke: Blutgerinnung und Leberfunktion. I. Mitteilung. Die Bestimmung von Acceleratorglobulin und Prothrombin als Leberfunktionsprobe. Dtsch. Arch. klin. Med. 200, 290 (1953).Google Scholar
  113. Lasch, H. G., U. A. Linke, Blutgerinnung und Leberfunktion. III. Mitteilung. Der Vitamin K-Test zur Differentialdiagnose des Ikterus. Dtsch. Arch. klin. Med. 200, 442 (1953).PubMedGoogle Scholar
  114. Lasch, H. G., U. L. Roka: Zur Prothrombinbildung in der Leber. Hoppe-Seylers Z. 294, 30 (1953).CrossRefGoogle Scholar
  115. Lewis, J. H., and J. H. Ferguson: Activation de la fibrinolysine. Rev. d’Hématol. 7, 6 (1952).Google Scholar
  116. Lewis, J. H., and J. H. Ferguson, Hemorrhagic diathesis due to PTC (plasma thromboplastin component) deficiency. Proc. Soc. Exper. Biol. A. Med. 82, 445 (1953).Google Scholar
  117. Ley, A.B., G. G. Reader, C. W. Sorenson and R. S. Overman: Idiopathic hypoprothrombinemia associated with hemorrhagic diathesis and the effect of vitamin K. Blood 6, 740 (1951).PubMedGoogle Scholar
  118. Linke, A.: Blutgerinnung und Leberfunktion. Verh. Ges. f. Verdauungs- u. Stoffwechselkrkh. XV. Tagung, Bad Kissingen, S. 123, 1950.Google Scholar
  119. Linke, A., U. H. G. Lasch: Blutgerinnung und Leberfunktion. II. Mitteilung. Der Tromexantest als Leberfunktionsprobe. Dtsch. Arch. Klin. Med. 200, 385 (1953).PubMedGoogle Scholar
  120. Loeliger, A., and F. Koller: Behaviour of factor VII and prothrombin in late pregnancy and in the Newborn. Acta Haematol. (Basel) 7, 157 (1952).Google Scholar
  121. Loomis, T. A.: Antithrombin and heparin in human blood. J. Labor, a. Clin. Med. 34, 631 (1949).Google Scholar
  122. Lovotti, A.: II fattore VII della coagulazione nella gravidanza fisiológica a termine. Minerva ginecol. 5, 521 (1953).PubMedGoogle Scholar
  123. Luescher, E., U. A. Labhart: Blutgerinnungsstörung durch körpereigene Antikoagulantien bei Hyperglobulinämie. Helvet. Med. Acta 16, 283 (1949).Google Scholar
  124. Macfarlane, R. G., and R. Biggs: A thrombin generation test. J. Clin. Path. 6, 3 (1953).PubMedCrossRefGoogle Scholar
  125. Macmillan, R. L.: Observations on the mechanism of action of dicumarol. Science (Lancaster, Pa.) 108, 416 (1948).Google Scholar
  126. Malagamba, G., U. M. Maneschi: Die Akzeleratorfaktoren: ihr klinisches Verhalten nach gynäkologischen Operationen mit Bezug auf die Diagnose der Thrombosebereitschaft. Zbl. Gynäk. 75, 659 (1953).Google Scholar
  127. Mann, F. D., and M. Hurn: Co-thromboplastin, a probable factor in coagulation of blood. Amer. J. Physiol. 164, 105 (1951).PubMedGoogle Scholar
  128. Mann, F. D., and M. Hurn, and T. B. Magath: Observations on the conversion of prothrombin to thrombin. Proc. Soc. Exper. Biol. A. Med. 66, 33 (1947).Google Scholar
  129. Marbet, R., U. A. Winterstein: Probleme der Blutgerinnung. V. Über die Wirkung von Antikoagulantien des Heparintvpus auf die 1. Phase der Blutgerinnung. Helvet. phvsiol. Acta 10, 528 (1952).Google Scholar
  130. Marbet, R., U. A. Winterstein, Neuere Auffassungen über den Mechanismus der Blutgerinnung. Experientia (Basel) 10, 274 (1954).CrossRefGoogle Scholar
  131. Marcacci, M.: Sindromi emofiliche: diagnosi di laboratorio. Medicina internazionale 1954.Google Scholar
  132. Martin, H., U. L. Roka: Beeinflussung der Blutgerinnung durch Leukocvten. Klin. Wschr. 1951, 510.Google Scholar
  133. Marx, R., U. H. Dyckerhoff: Über Vitamin K und Plasmaeiweiß. Klin. Wschr. 1943, 570.Google Scholar
  134. Matis, P.: Marcumar (3-(1′-phenvl-propvl)-4-oxy-cumarin, ein neues Superdicumarol. Ärztl. Forsch. 7, 298 (1953).Google Scholar
  135. Matis, P., Substancia heparinoidea en la terapéutica de las thromboembolias. Folia Clin. Internacional 1, 318 (1951).Google Scholar
  136. Merskey, C.: The laboratory diagnosis of hemophilia. J. Clin. Path. 3, 301 (1950).PubMedCrossRefGoogle Scholar
  137. Merskey, C.: Hemophilia associated with normal coagulation time. Brit. Med. J. 1, 906 (1951).PubMedCrossRefGoogle Scholar
  138. Merz, W. R.: Behandlung der Thrombose und Lungenembolie mit Antikoagulantien. Gynecologia suppl. 1950, 130.Google Scholar
  139. Merz, W. R.: Richtlinien für die antikoagulierende Therapie der schweren postoperativen und postpartalen akuten Venenthrombose. Schweiz, med. Wschr. 1954, 315.Google Scholar
  140. Miale, J. B.: The role of coagulase-globulin in blood coagulation and its thromboplastic action. With particular reference of the defect in hemophilia. Amer. J. Clin. Path. 22, 218 (1952).Google Scholar
  141. Moolten, S. E., L. Vroman and G. M. S. Vroman: Adhesiveness of blood platelets in thromboembolism and hemorrhagic disorders. II. Diagnostic and prognostic significance of platelet adhesiveness. Amer. J. Clin. Path. 19, 814 (1949).Google Scholar
  142. Moolten, S. E., L. Vroman and G. M. S. Vroman and B. Goodman: Role of blood platelets in thromboembolism. Arch. Int. Med. 84, 667 (1949).CrossRefGoogle Scholar
  143. Morrison, P. R., and F. Doppelt: Adhesion of fibrin clots to tissue. Federat. Proc. 11, 262 (1952).Google Scholar
  144. de Nicola, P.: Contributo allo studio della vitamina K nei suoi rapporti conia protrombinemia e le sostanze ostacolo. Boll. Soc. med.-chir. Pavia 57, 1427 (1944).Google Scholar
  145. de Nicola, P.: Trattamento delle ipereparinemie con protamina intramuscolare ad effetto prolungato. Progr. med. 7, 300 (1951).Google Scholar
  146. de Nicola, P.: Durata d’azione, neutralizzazione con protamina ed eliminazione urinaria dell’eparina intramuscolare in soluzione acuosa. Farmaco 6, 56 (1951).Google Scholar
  147. de Nicola, P.: Über die Entstehungsdauer der Blutgerinnungsfaktoren und ihre Verweildauer im Kreislauf. Klin. Wschr. 1951, 278.Google Scholar
  148. de Nicola, P.: Zur physiopathologischen Einteilung der hämorrhagischen Diathesen. Neue med. Welt 20, 735 (1951); Physiopathological classification of hemorrhagic diseases. Canad. Med. Assoc. J. 67, 623 (1952).Google Scholar
  149. de Nicola, P.: Revisione sperimentale dei metodi di controllo della terapia anticoagulante con derivati dicumarinici. Haematologica (Pavia) 36, 9 (1952). Acerca de la vigilancia terapeutica anticoagulante con los derivados de la dicumarina. Folia clin. internacional 2, 73 (1952).Google Scholar
  150. de Nicola, P.: Ein Benetzbarkeits-Index zur Auswertung der Oberflächenerscheinungen bei der Blutgerinnung. Klin. Wschr. 1952, 512.Google Scholar
  151. de Nicola, P.: Zur Kontrolle der Antikoagulantientherapie mit (Bis-(4-Oxycumarinyl)-3,3’)-Essigsäure- äthylester durch die Faktor VII-Bestimmung. Klin. Wschr. 1952, 512.Google Scholar
  152. de Nicola, P.: Research on the new clotting factors. Texas Rep. Biol. a. Med. 11, 3 (1953).Google Scholar
  153. de Nicola, P.: Factor VII (Spca): its Physiopathologie significance. Blood 8, 947 (1953); Beitrag zur Charakterisierung des Faktors VII. Schweiz, med. Wschr. 1953, 1047; Significato clinico del fattore VII. Progr. med. 9, 118 (1953).Google Scholar
  154. de Nicola, P.: Zur zuverlässigen Durchführung der Zweistufenmethoden bei der Blutgerinnung. Klin. Wschr. 1954, 355.Google Scholar
  155. de Nicola, P.: and L. Berman: In Vorbereitung.Google Scholar
  156. de Nicola, P., e A. Colli: Problemi attuali di diagnosi e terapie delle malattie tromboemboliche. Boll. Soc. med.-chir. Pavia 58, 234 (1954).Google Scholar
  157. de Nicola, P., A. Colli, E. P. Rosti: Terapia anticoagulante con preparati ad azione dicumarinica prolungata (3-1-fenil-propil)4-ossi-cumarina. Azione antidotica della vitamina Kx sintetica. Haematologica (Pavia) 88, 56 (1954).Google Scholar
  158. de Nicola, P., A. Colli, e G. R. Mazzetti: Valore clinico della trombelastografia. Haematologica (Pavia). Im Druck.Google Scholar
  159. de Nicola, P., A. Colli, e P. Rosti: La coagulazione del sangue decalcificato con la resina amberlite. Boll. 1st. sieroterap. milanese 27, 180 (1948).Google Scholar
  160. de Nicola, P., e A. Colli: Sulle fibrinogenopenie e ipoprothrombinemie sperimentali da infusione di trombina. Boll. Soc. ital. Biol. sper. 25, 1184 (1949).Google Scholar
  161. de Nicola, P., e A. Colli: Method for the quantitative evaluation of functional activity in isolated platelets. Experientia (Basel) 10, 24 (1954).CrossRefGoogle Scholar
  162. de Nicola, P., A. Colli, and C. Carcupino: Quantitative evaluation of functional activity in siolated platelets. IV. Internat. Congr. Europ. Soc. Hematol., Amsterdam, 1953; Isolamento e studio funzionale delle piastrine nella coagulazione del sangue. Boll. Soc. med.-chir. Pavia 68, 637 (1954).Google Scholar
  163. de Nicola, P., A. Colli, and C. Carcupino: Studio fisiopatologico e clinico della funzione tromboplastinica nelle piastrine isolate. Haematologica (Pavia) 38, 1036 (1954).Google Scholar
  164. de Nicola, P., A. Colli, and C. Carcupino: Ricerche sulle piastrine isolate. II. Perfezionamenti tecnici per lo studio dell’agglutinazione di piastrine normali da parte di sieri di piastrinopenici. Boll. Soc. ital. Ematol. 2, 78 (1954).Google Scholar
  165. de Nicola, P., A. Colli, E C. Grugni: Variazioni del fattore VII e del fattore labile negli stati postoperatori: rapporti con la diagnosi e la terapia delle malattie tromboemboliche Gazz. internaz. med. e chir. 58, 439 (1954).Google Scholar
  166. Nilsson, I. M., and A. Wenckert: Hyperglobulinemia as the cause of hemophilia-like disease. Blood 8, 1067 (1953).PubMedGoogle Scholar
  167. Ninni, M.: Dimostrazione di una attività piastrinlotica presente in vitro nel siero di sangue degli ammalati di porpora piastrinopeniea essenziale. Haematologica (Pavia) 36, 693 (1953).Google Scholar
  168. Nolf, P.: The coagulation of blood. Medicine 17, 381 (1938).CrossRefGoogle Scholar
  169. Orr, W. F., and M. E. Gray: Accelerators factors in hemophilic blood. Amer. J. Physiol. 163, 148 (1950).PubMedGoogle Scholar
  170. Overman, R. S., C. W. Sorenson and I. S. Wright: Effectiveness of synthetic watersoluble vitamin K preparations in bishydroxvcoumarin-induced hypoprothrombinemia. J. Amer. Med. Assoc. 145, 393 (1951).CrossRefGoogle Scholar
  171. Owen, C. A. Jr., and J. L. Bollmann: Prothrombin conversion factor of dicumarol plasma. Proc. Soc. Exper. Biol. a. Med. 67, 231 (1948).Google Scholar
  172. Owren, P. A.: The coagulation of blood. Investigations on a new clotting factor. Acta med. scand. (Stockh.) suppl. 194, (1947).Google Scholar
  173. Owren, P. A.: Le complexe activateur de la prothrombine et son interèt clinique. Rev. d’Hématol. 6, 135 (1951).Google Scholar
  174. Owren, P. A.: Is Bl2 The Complete Therapeutic Answer In Pernicious Anemia ? Proc. Internat. Congr. Soc. Hematol., P. 22. New York: Grune and Stratton 1951.Google Scholar
  175. Owren, P. A. and K. Aas: The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. Clin. a. Lab. Invest. 3, 201 (1951).CrossRefGoogle Scholar
  176. Owren, P. A.: La proconvertine. Rev. d’Hématol. 7, 147 (1952).Google Scholar
  177. Pavlovsky, A.: Vascular factors in hemophilia. Acta haematol. (Basel) 3, 65 (1950).Google Scholar
  178. Pavlovsky, A., D. Mittelman Y H. Castellanos: Consuncion de protrombina. Rev. Soc. argent. Hematol. 1, 305 (1949).Google Scholar
  179. Perlick, E.: Der Einfluß des Phenylindandions ( P.I.D.) auf die Gerinnungsfaktoren Prothrombin, Faktor V und Faktor VII und die Frage der Vitamin K-Resistenz. Klin. Wschr. 1953, 26.Google Scholar
  180. Pisciotta, A. V., M. Stefanini and W. Dameshek: Studies on platelets. X. Morphologie characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood 8, 703 (1953).PubMedGoogle Scholar
  181. Poole, J. C. F.: A haemorrhagic state resembling hemophilia. Lancet 1953, 122.Google Scholar
  182. Quattrin, X.: Le diatesi emorragiche trombopatiche. Minerva med. ( Torino ) 1949.Google Scholar
  183. Quick, A. J.: On the constitution of prothrombin. Amer. J. Physiol. 140, 212 (1943).Google Scholar
  184. Quick, A. J.: Components of the prothrombin complex. Amer. J. Physiol. 151, 63 (1947).PubMedGoogle Scholar
  185. Quick, A. J.: Studies on the enigma of the hemostatic dvsfunction of hemophilia. Amer. J. M. Sci. 214, 272 (1947).CrossRefGoogle Scholar
  186. Quick, A. J.: Pediatric aspects of hemophilia. Pediatrics 3, 312 (1949).PubMedGoogle Scholar
  187. Quick, A. J.: Is action of calcium on coagulation of blood stoichiometric or catalytic? Science (Lancaster, Pa.) 106, 591 (1947).Google Scholar
  188. Quick, A. J.: The Physiology and Pathology Of Hemostasis. Philadelphia: Lea and Febiger 1951.Google Scholar
  189. Quick, A. J., and E. Epstein: Thromboplastin activity in human blood. J. Appi. Physiol. 4, 840 (1952).Google Scholar
  190. Quick, A. J., and J. Favre-Gilly: Fibrin, a factor influencing the consumption of prothrombin in coagulation. Amer. J. Physiol, 158, 387 (1949).PubMedGoogle Scholar
  191. Quick, A. J., and C. V. Hussey: Hemophilia: clinical and laboratory observations relative to diagnosis and inheritance. Amer. J. Med. Sci. 223, 401 (1952).PubMedCrossRefGoogle Scholar
  192. Quick, A. J., and C. V. Hussey: The mechanism of clot retraction. Science (Lancaster, Pa.) 112, 558 (1950).Google Scholar
  193. Quick, A. J., J. N. Shanberge and M. Stefanini: The coagulation defect in thrombocvtopenic purpura. J. Labor, a. Clin. Med. 34, 761 (1949).Google Scholar
  194. Quick, A. J. and M. Stefanini: Nature of action of the labile factor in formation of thrombin. Amer. J. Physiol. 160, 572 (1950).PubMedGoogle Scholar
  195. Quick, A. J., W. F. Stopp and C. V. Hussey: The effect of heating on the thromboplastic activity of rabbit brain extract. A new test for the diagnosis of hemophilia. J. Labor, a. Clin. Med. 39, 142 (1952).Google Scholar
  196. Ratnoff, O. D.: Studies on a proteolytic enzyme in human plasma. VII. Alterations in plasma fibrinogen and proteolytic activity in pneumonia. Bull. Hopkins Hosp. 88, 304 (1951).PubMedGoogle Scholar
  197. Reimann, F.: Purpura thrombolytica. Acta med. scand. (Stockh.) 107, 95 (1941).Google Scholar
  198. Rieben, W.: Beiträge zur Kenntnis der Blutgerinnung. Basel: Benno Schwabe 1947.Google Scholar
  199. Rosenthal, R. L., O. H. Dreskin and N. Rosenthal: New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc. Soc. Exper. Biol. a. Med. 82, 171 (1953).Google Scholar
  200. Rossini, G., E P. Rosti: Le variazioni del fattore labile della protrombina in soggetti tubercolotici trattati con ac. paraminosalicilico. Acta vitaminol. 5, 12 (1951).Google Scholar
  201. Rosti, P., E R. Furian: Sulle variazioni della protrombina residua durante il ciclo mestruale nella donna normale. Haematologica (Pavia) 35, 477 (1951).Google Scholar
  202. Rosti, P., E S. Marigo: Vitamina B12, estratti epatici e ipoprotrombinemia nell’anemia perniciosa. Progr. med. 8, 500 (1952).Google Scholar
  203. Rosti, P., E O. Zangaglia: Modificazioni della coagulabilità plasmatica indotte nel coniglio dalla somministrazione di bis(2-cloroetil) beta-naftilmaina. Arch. Sci. med. 78, 515 (1953).Google Scholar
  204. Salvidio, E.: Microchimica delle piastrine umane. Progr. med. 9, 562 (1953).Google Scholar
  205. Della Santa, R.: Une nouvelle méthode de dépistage des diathéses thrombophiles. La thrombélastographie selon Hartert. Praxis (Bern) 43, 89 (1954).Google Scholar
  206. Della Santa, R. et R. Faller: Valeur du temp de coagulation dans le traitement dicoumarinique. Schweiz, med. Wschr. 1951, 1242.Google Scholar
  207. Della Santa, R. et K. N. Vonkaulla: L’hypoprothrombinémie provoqués chez les hépatiques. Helvet. med. Acta 16, 251 (1949).Google Scholar
  208. Sauthoff, R.: Zur Frage der Thrombopathien. III. Teil. Vergleichende phasenkonstrast. und elektronenmikroskopische Untersuchungen an normalen und pathologischen Thrombocyten. Ärztl. Wschr. 1951, 637.Google Scholar
  209. Scardigli, G., E G. Guidi: Modificazioni dell’attività protrombinica sotto carico di vitamin K e di tromexan ai fini della diagnostica funzionale epatica. Arch, fisiopatol. e clin, del ricambio 17, 61 (1953).Google Scholar
  210. Schneider, C. L.: Abruptio placentae after fetal death in utero. Obstetr. Gynec. 1, 321 (1953).Google Scholar
  211. Schulman, L., and C. Smith: Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood 7, 794 (1952).PubMedGoogle Scholar
  212. Schultze, H. E.: Neuere Erkenntnisse über das Prothrombin und das Accelerator-Globulin von Seegers. Dtsch. med. Wschr. 1950, 607.Google Scholar
  213. Schultze, H. E., U. G. Schwick: Bedeutung der differenzierten Bestimmung von Prothrombin und Acceleratoren bei der Blutgerinnung. Die Medizinische 1953, 1354, 1386.Google Scholar
  214. Schwarz, E., C. Usteri U. F. Koller: Heparinresistenz und Heparinüberempfindlichkeit. Acta haematol. (Basel) 4, 148 (1950).Google Scholar
  215. Schwarz, E., J. Wanner U. F. Koller: Über ein antithrombisch wirkendes Anticoagulans bei Leber-krankheiten. Acta haematol. (Basel) 6, 70 (1951).Google Scholar
  216. Schwick, G.: Über die Differenzierung von Hämophilie A und B. Klin. Wschr. 1954, 171.Google Scholar
  217. Seegers, W. H.: A new antithrombin reaction. Arch, of Biochem. 36, 484 (1952).CrossRefGoogle Scholar
  218. Seegers, W. H.: Blood coagulation. Harvey Lect. 47, 180 (1953).Google Scholar
  219. Seegers, W. H., R. J. Mcclaughry and J. L. Fahey: Some properties of purified prothrombin and its activation with sodium citrate. Blood 5, 421 (1950).PubMedGoogle Scholar
  220. Seegers, W. H., K. D. Miller, E. B. Andrews and R. C. Murphy: Fundamental interactions and effect of storage, ether, adsorbants and blood clotting on plasma antithrombin activity. Amer. J. Physiol. 169, 700 (1952).PubMedGoogle Scholar
  221. Seegers, W. H., M. Nieft and E. C. Loomis: Note on the adsorption of thrombin on fibrin. Science (Lancaster, Pa.) 101, 520 (1945).Google Scholar
  222. Serafini, U. M., E G. Siciliano: Sindrome emorragica mortale postpartum con incoagulabilità sanguigna da fibrinolisi. Progr. med. 9, 433 (1953).Google Scholar
  223. Sloan, A. W.: The normal platelet count in man. J. Clin. Path. 4, 37 (1951).PubMedCrossRefGoogle Scholar
  224. Snellman, O., B. Sylven and C. Julen: Analysis of the native heparinlipoprotein complex including the identification of a heparin complement (heparin co-factor) obtained from extracts of tissue mast cells. Biochim. et Biophysica Acta 7, 98 (1951).CrossRefGoogle Scholar
  225. Sorbye, O., J. Kruse and H. Dam: The factor in dicumarol plasma which accelerates the coagulation of plasma from vitamin K deficient chicks. Acta chem. scand. (Stockh.) 4, 831 (1950).Google Scholar
  226. Sorbye, O., J. Kruse and H. Dam: The factor in vitamin K-deficient plasma which accelerates the coagulation of dicumarol plasma. Acta chem. scand. (Stockh.) 4, 549 (1950).Google Scholar
  227. Soulier, J. P.: La consommation de la prothrombine pendant la coagulation du sang veineux et du sang capillaire. Nouvelle méthode d’investigation des syndromes hémorrhagiques. Rev. d’Hématol. 3, 302 (1948).Google Scholar
  228. Soulier, J. P.: Apparition d’une antithrombine, a la suite d’injections de thrombine, chez un hémophilie ayant présenté un anticoagulant circulant. Rev. d’Hématol. 8, 39 (1953).Google Scholar
  229. Soulier, J. P. et M. J. Larrieu: Differentiation of hemophilia into two groups. A study of thirty-three cases. New England J. Med. 249, 547 (1953).CrossRefGoogle Scholar
  230. Soulier, J. P. et M. J. Larrieu: Syndrome de Willebrand-Jürgens et thrombopathies. etude de 65 cas. Essai de classification. Rev. d’Hématol. 9, 77 (1954).Google Scholar
  231. Soulier, J. P. et A. G. Le Bolloch: Le test de tolerance a l’héparine in vitro. Rev. d’Hématol. 5, 147 (1950).Google Scholar
  232. Soulier, J. P., J. Mathey, A. G. Le Bolloch, Ph. Daumet et H. Fayet: Syndromes hemorrhagiques mortels avec incoagulabilité totale par défibrination et avec fibrinolyse. I. Au cours des exérés pulmonaires. Rev. d’Hématol. 7, 30 (1952).Google Scholar
  233. Soulier, J. P., P. Petit et A. G. Le Bolloch: Syndromes hémorrhagiques mortels avec incoagulabilité totale par defibrination avec f ibrinolyse. II. A la suite d’un avortement par injection intra-uterine d’eau de Javel. Rev. d’Hématol. 7, 48 (1952).Google Scholar
  234. Stefanini, M.: Antithrombin activity of stored plasma. Amer. J. Clin. Path. 18, 537 (1949).Google Scholar
  235. Stefanini, M.: Activity of plasma labile factor in disease. Lancet 1951, 606.Google Scholar
  236. Stefanini, M.: Analytic Review: Conversion factors and accelerators in the formation of thrombin. Blood 6, 84 (1951).PubMedGoogle Scholar
  237. Stefanini, M.: Mechanism of blood coagulation in normal and pathologic conditions. Amer. J. Med. 14, 64 (1953).PubMedCrossRefGoogle Scholar
  238. Stefanini, M., E. W. Campbell, G. I. Plitman and L. Salomon: Coagulation defects due to acquired anticoagulants and fibrinolysis: their detection and treatment. Bull. New England Med. Center 15, 23 (1953).Google Scholar
  239. Stefanini, M. and J. B. Chatterjea: Studies on platelets. A thrombocytopenic factor in normal human blood, plasma or serum. Proc. Soc. Exper. Biol. a. Med. 79, 623 (1952).Google Scholar
  240. Stefanini, M. and W. H. Crosby: Complementary correction of the defective coagulation mechanism of hemophilic and thrombocytopenic blood. Proc. Soc. Exper. Biol. a. Med. 73, 301 (1950).Google Scholar
  241. Stefanini, M., W. Dameshek, J. B. Chatterjea, E. Adelson and J. B. Mednicoff: Studies on platelets. IX. Observations on the properties and mechanism of action of a potent agglutinin detected in the serum of a patient with idiopathic thrombocytopenic purpura (with a note on the pathogenesis of the disease). Blood 8, 26 (1953).PubMedGoogle Scholar
  242. Stefanini, M. and R. B. Gendel: Influence of fibrinolysin on the survival “in vivo” of various coagulation factors and favorable effect of cortisone in “fibrinolytic purpura”. Clin. Res. Proc. 1, 5 (1953).Google Scholar
  243. Stevenson, C. S., R. G. Braden, C. J. Schneider, J. F. Johnson and W. H. Seegers: Hemorrhagic diathesis in abruptio placentae. Amer. J. Obstetr. 65, 88 (1953).Google Scholar
  244. Storti, E., S. Perugini E M. Soldati: Le modificazioni del contenuto polisaccaridico delle cellule ematiche in alcune emopatie e malattie infettive (ricerche citochimiche). Raccolta di pubblicaz. biol., chini, e med., Carlo Erba, 1, 475 (1953).Google Scholar
  245. Tagnon, H. J., P. Schulman, W. F. Whitmore and L. A. Leone: Prostatic fibrinolysin. Study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate. Amer. J. Med. 15, 875 (1953).PubMedCrossRefGoogle Scholar
  246. Thies, H. A., U. D. Boecker: Klinische Erfahrungen mit einem neuen Antithromboticum aus der Gruppe der seltenen Erden. Dtsch. med. Wschr. 1953, 222.Google Scholar
  247. Tocantins, L. M., R. T. Carrol and R. H. Holburn: The clot accelerating effect of dilution on blood and plasma. Relation to the mechanism of coagulation of normal and hemophilic blood. Blood 6, 720 (1951).PubMedGoogle Scholar
  248. Tropeano, L.: Il consumo della protrombina nel sangue emofilico e similemofilico dopo aggiunta in vitro di sangue normale fresco. Boll. Soc. ital. Biol. sper. 28, 1890 (1952).PubMedGoogle Scholar
  249. Uehlinger, E.: Über eine Blutgerinnungsstörung bei Dysproteinämie (Beitrag zur Kenntnis der körpereigenen Antikoagulantia). Helvet. med. Acta 16, 508 (1949).Google Scholar
  250. Ungar, G., and E. Damgaard: Studies on the fibrinolysin-antifibrinolysin system in serum. I. Action of the anterior pituitary, adreanol cortex and spleen. J. of Exper. Med. 93, 89 (1951).Google Scholar
  251. Unger, P. X., and S. Shapiro: The prothrombin response to the parenteral administration of large doses of vitamin K in subjects with normal liver function and in cases of liver disease: a standardized test for the estimation of hepatic function. J. Clin. Invest. 27, 39 (1948).CrossRefGoogle Scholar
  252. Usteri, C.: Das Heparinkomplement und Scine physiologisch-klinische Bedeutung. Inaug.- Diss. Zürich, 1949.Google Scholar
  253. Van Creveld, S., and M. M. P. Paulssen: Isolation and properties of the third clotting factor in blood platelets. Lancet 1952, 23.Google Scholar
  254. Haemorrhagic diathesis due to absence of Christmas factor. Lancet 1953, 823.Google Scholar
  255. Vecchietti, G.: Contributo allo studio delle emorragie post-partum per afibrinogenemia (sull’azione anticoagulante e fibrinolitica del liquido amniotico nei casi di macerazione fetale). Riv. ostetr. e ginecol. 8, 443 (1953).Google Scholar
  256. Vetni, G., A. R. Axelrod and S. A. Johnson: Studies of the inadeguacv of vitamin B12 therapy in patients with pernicious anemia. Second Annual Symposium on Blood. Detroit 1953.Google Scholar
  257. De Vries, A., and E. Shafrir: Hemorrhagic diathesis in a case of biliary cyrrhosis associated with a circulating anticoagulant. Acta haematol. (Basel) 8, 246 (1952).Google Scholar
  258. De Vries, A., and E. Shafrir: Méthode d’evaluation de l’activité thromboplastique du plasma. Applications cliniques et physiologiques. Rev. d’Hématol. 7, 481 (1952).Google Scholar
  259. P. Efrati and Z. Shamir: Thrombocvtopathic purpura with normal prothrombinconsumption. Hemorrhagic diathesis due to partial platelet dysfunction. Blood 8, 1000 (1953).PubMedGoogle Scholar
  260. Ware, A. G., J. L. Fahey and W. H. Seegers: Platelet extracts, fibrin formation and interaction of purified prothrombin and thromboplastin. Amer. J. Physiol. 154, 140 (1948).PubMedGoogle Scholar
  261. Ware, A. G., M. M. Guest and W. H. Seegers: A factor in plasma which accelerates the activation of prothrombin. J. of Biol. Chem. 169, 231 (1947).Google Scholar
  262. Ware, A. G., M. M. Guest and W. H. Seegers: Plasma accelerator factor and purified prothrombin activation. Science (Lancaster, Pa.) 106, 41 (1947).Google Scholar
  263. Ware, A. G. and W. H. Seegers: In Trans. First Conference on Blood Clotting and Allied Problems. New York: Josiah Macy, Jr. Foundation 1948.Google Scholar
  264. Ware, A. G. and W. H. Seegers: Studies on prothrombin: purification, inactivation with thrombin and activation with thromboplastin and calcium. J. of Biol. Chem. 174, 565 (1948).Google Scholar
  265. Ware, A. G. and W. H. Seegers: Two-stage procedure for the quantitative determination of prothrombin concentration. Amer. J. Clin. Path. 19, 471 (1949).Google Scholar
  266. White, S. G., P. M. Aggeler and M. B. Glendening: Plasma thromboplastin component (PTC). A hitherto unrecognized blood coagulation factor. Case report of PTC deficiency. Blood 8, 101 (1953).PubMedGoogle Scholar
  267. Wildbrand, U.: Die klinische Anwendung des neuen Anticoagulans Thrombodym. Dtsch. med. Wschr. 1953, 330.Google Scholar
  268. Winterstein, A.: Nuovi concetti sulla determinazione della protrombina. Problemi attinenti alla coagulazione del sangue. Atti del primo simposio. Genova, dicembre 1953. Prodotti Roche S. P.A., Milano.Google Scholar
  269. Witte, S.: Über die Methode der Prothrombinzeitbestimmung und ihren diagnostischen Wert in der inneren Medizin. Z. klin. Med. 145, 547 (1949).Google Scholar
  270. Witte, S.: Der Vitamin K-Test mit Bestimmung von Prothrombin und Ac-Globulin bei Leberkrankheiten. Dtsch. Z. Verdauungs- u. Stoffwechselkrkh. 11, 209 (1951).Google Scholar
  271. Witte, S., U. P. Dirnberger: Die Gerinnungsfaktoren V Und VII In Der Zweiphasen-Prothrombin-Bestimmung. Klin. Wschr. 30, 610 (1952).PubMedCrossRefGoogle Scholar
  272. Witte, S., U. P. Dirnberger: Über quantitative Beziehungen zwischen den Gerinnungsfaktoren V und VII bei der Prothrombinaktivierung. Acta haematol. (Basel) 9, 380 (1953).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1955

Authors and Affiliations

  • Pietro de Nicola
    • 1
  1. 1.PaviaItaly

Personalised recommendations